Clinical Trials Browser

Phase 1 × siplizumab × Other hematologic neoplasm × Clear all

NCT00105313 2007-06-14

Study to Evaluate MEDI-507 in Patients With CD2-Positive Lymphoma/Leukemia

Phase 1 Terminated

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Neoplasms